Aperio Group’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-43,403
| Closed | -$486K | – | 2285 |
|
|
2017
Q3 | $486K | Buy |
43,403
+14,593
| +51% | +$163K | ﹤0.01% | 1673 |
|
|
2017
Q2 | $317K | Buy |
28,810
+5,026
| +21% | +$55.3K | ﹤0.01% | 1866 |
|
|
2017
Q1 | $233K | Buy |
23,784
+11,608
| +95% | +$114K | ﹤0.01% | 1963 |
|
|
2016
Q4 | $132K | Sell |
12,176
-1,007
| -8% | -$10.9K | ﹤0.01% | 2062 |
|
|
2016
Q3 | $135K | Buy |
13,183
+1,690
| +15% | +$17.3K | ﹤0.01% | 1998 |
|
|
2016
Q2 | $150K | Buy |
11,493
+1,125
| +11% | +$14.7K | ﹤0.01% | 1930 |
|
|
2016
Q1 | $114K | Buy |
+10,368
| New | +$114K | ﹤0.01% | 1962 |
|